
Interventional Cardiologist @lenoxhill / @ZuckerSoM🫀| Interests #CHIP #PERT #CardiacCriticalCare | Previously @nymedcollege @PennMedicine | tweets are my own |
New York, NY
Joined March 2017
- Tweets1.9K
- Following597
- Followers1.4K
- Likes7.6K
Atul D. Bali, MD retweeted
And here we are! Hot off the press. Introducing the 2026 SCAI SHOCK classification update!
Link: jscai.org/article/S2772-9303…
@SCAI @davebaran @agtruesdell @Babar_Basir @SandeepNathanMD @vbluml @Allison_Dupont @JasonKatzMD
@ShashankSinhaMD @NavinKapur4 @mwkrucoff @AHAScience
Ok the time has come!
This Sunday at #AHA2026 we unveil the 2026 SCAI SHOCK classification update, presented by my co-chair @davebaran on behalf of the writing group & all endorsing societies! Simultaneous publication in @MyJSCAI.
Lots of new updates to provide clarity, granularity, consensus and direction to level-set the field!
Details below ⬇️
@AlexandraLansky @agtruesdell @SCAI @Babar_Basir @vbluml @debdiercks @Allison_Dupont @HenrytTimothy @JasonKatzMD @SandeepNathanMD @mwkrucoff @ShashankSinhaMD @SarasVallabhMD @seanvandiepen @mirvatalasnag @DLBHATTMD @djc795 @TCTMD @CardioBusiness @theheartorg @nymedcollege @ACCinTouch @AHAScience @STS_CTsurgery @SCCMPresident @ISHLT
Atul D. Bali, MD retweeted
Key updates to this guideline include:
➡️ The use of the American Heart Association PREVENT-ASCVD equations to guide primary-prevention and lipid-lowering therapy decisions.
➡️ Testing Lp(a) at least once in a lifetime and selective apolipoprotein B measurement to improve risk assessment and guide treatment
➡️ The return of LDL-C and non-high-density lipoprotein cholesterol treatment goals (with lower targets for higher-risk groups)
➡️ Expanded use of coronary artery calcium scoring to reclassify risk[ME1.1]
✍🏼 @rblument1 @tygluckman @RonBlankstein @PamelaBMorris @pnatarajanmd @AnnMarieNavar @SethShayMartin @APRN_CNS @nyulangone @DrMichaelShapir @kgradneyrd @eugeniagianos @virani_md @KellieMcLain1 @ijeomaheartdoc @SamiaMoraMD @DrHeatherJohn @dmljmd
Atul D. Bali, MD retweeted
This week we hosted the first edition of the Northwell Cardiogenic Shock Skills day. Over 50 junior faculty members and fellows from cardiology, IC, CTS & CCM joined a day of hemodynamic simulations, hands-on tMCS and PAC learning and expert discussions of real-life CS cases.
Atul D. Bali, MD retweeted
“Every physician carries within himself a small cemetery, where from time to time he goes to pray.” — René Leriche
The guilt is real. Each name finds its place there, quiet and heavy.
What surprises me still are the families who meet loss with gratitude—who somehow thank you through their own heartbreak. That grace stays with you far longer than the failure ever does.
Atul D. Bali, MD retweeted
4/ The incidence of abnormal FFR in the side branch with angiographic significant stenosis after MV stenting varies between 27% to 52%.
1. Koo et al. 2005. 27%.
2. Ahn et al. 2012 (for DS >50% QCA). 28.4%
3. Kang et al. 2013 (for DS >50%). 32%
4. DK CRUSH VI trial. 52%
@SVRaoMD
1/ To tag along this excellent discussion, a poll and a case to follow. In crossover stenting, we not too infrequently see "pinched" side branch. This can be plaque shift, carinal shift or MACH effect. @realarainmd @sbrugaletta @PurumittalDr @evandrofilhobr @Hragy @aspergian1
Atul D. Bali, MD retweeted
Curious about the impact of "door-to-RV unload time" in PE treated w/ percutaneous interventions? Dive into our latest article in @CircIntv to find out👇
🔗ahajournals.org/doi/10.1161/…
& don't miss the insightful editorial by @sanjum ⤵️
🔗ahajournals.org/doi/10.1161/…
@SripalBangalore
Atul D. Bali, MD retweeted
#HDRanalysis - Happy New Year Edition! 🧵
The first #HDRanalysis of 2025!
The case was posted earlier by @evandrofilhobr - a man who needs no introduction here.
There were three #HDR injections - with three(!) different patterns.
Case below, my analysis to follow…
#CTO101 #HDR #CTOPCI
Interesting RCA CTO PCI
@realarainmd maybe I get honor to get your inputs in this case...
Still don't know how to name the crossing technique lol !😅 (I'm sure the patient don't care!)
Atul D. Bali, MD retweeted
In @ccijournal, we examine real-world outcomes of CDT vs CBT in acute PE, placing our findings in the context of the recently published #PEERLESS trial
🔗onlinelibrary.wiley.com/doi/…
@SripalBangalore @CardsNYC @jameshorowitzmd @btaslakianMD @peter_szz @PERTConsortium
Atul D. Bali, MD retweeted
Intra-Coronary Imaging 👁️ for Complex Lesion Subsets (and ideally for all-comers): academic.oup.com/ehjimp/adva……
Atul D. Bali, MD retweeted
We discussed this observation on #CardioTwitter: several noted that administering a heparin bolus the ER (100 units/Kg, not max 4,000), rather than waiting until the cath lab, improves TIMI flow by the time the patient reaches the cath lab. This is now supported by an RCT! #TCT2024 @crfheart
Atul D. Bali, MD retweeted
Substudy of DanGer Shock trial: microaxial flow pump reduced need for vasoactive drugs while maintaining hemodynamic stability & achieving faster normalization of lactate levels in pts w/ cardiogenic shock after ST-elevation myocardial infarction. #TCT2024 ja.ma/3Adk5Oy
Atul D. Bali, MD retweeted
Today on behalf of the investigators at TCT, I was honored to present the results of the Impella ECP pivotal trial. I extend my congratulations for this major milestone in the space of MCS to all my co investigators, research teams, and sponsor Abiomed. Small bore MCS is here!
Atul D. Bali, MD retweeted
Wow! Practice changing EARLY TAVR RCT. For a long time, we waited for aortic stenosis patients to become symptomatic before considering therapy, based on old data (risk of surgery vs watchful waiting). ASYMPTOMATIC patients with severe AS, TAVR leads to a major reduction in MACE with a NNT of just 6. #TCT2024
Atul D. Bali, MD retweeted
More “why-when MCS” for high-risk PCI: “Clinical Outcomes of Patients Experiencing Transient Loss of Pulse Pressure During High-Risk PCI with Impella”👉: 🔗 onlinejcf.com/article/S1071-……
Atul D. Bali, MD retweeted
Replying to @SandeepNathanMD @TheLancet @thiele_holger @WilcoxHeart @Babar_Basir @Allison_Dupont @agtruesdell @BurkhoffMd @ShashankSinhaMD @DocSavageTJU
When can we stop talking about “routine use of MCS in shock”. There is nothing routine about MCS or shock. That’s like saying routine use of Rotational Atherectomy for PCI is a bad idea. Does not advance clinical practice. The big BUT in the abstract conclusion says it all.
Atul D. Bali, MD retweeted
Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction With or Without ST-Segment Elevation: @JACCJournals
🥸 A subanalysis of the Fire Trial: Physiology guided complete revascularization in older adults works!
😱 Summary
👇👇👇
Atul D. Bali, MD retweeted
📢How are you risk stratifying your pts with intermediate risk PE? Have you considered using the CPES score? ✅out our latest 📜 in @CircIntv showing that the CPES score predicts adverse outcomes in PE.
🔗ahajournals.org/doi/10.1161/…
@SripalBangalore @SVRaoMD @CardsNYC
A short 🧵 ⤵️









































